AVTX vs LYRA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AVTX Captures Institutional Edge (2โ1 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avalo Therapeutics, Inc. Common Stock (AVTX) driven by superior Growth & Margin, Momentum & Technical while LYRA counters with relative strength in Options & Structure. Fundamentally, AVTX trades at N/M Forward P/E with -161962.7% operating margin (-69.3% YoY revenue) versus LYRA at N/M Forward P/E and -25032.0% operating margin (-87.2% YoY). In options structure, AVTX sits in BREAKDOWN (22nd %ile IV; Dealer Gamma Walls on Pro) against LYRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | AVTX Revenue | LYRA Revenue | AVTX Op. Margin | LYRA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $10M | N/A | -503.4% | N/A | AVTX |
| FY2019 | $10M | N/A | -239.1% | N/A | AVTX |
| FY2020 | $10M | N/A | -1087.4% | N/A | AVTX |
| FY2021 | $10M | $0M | -1521.6% | -15303.5% | AVTX |
| FY2022 | $20M | $0M | -207.4% | -4131.0% | AVTX |
| FY2023 | $0M | $0M | -1421.6% | -4308.1% | AVTX |
| FY2024 | $0M | $0M | -15535.6% | -6280.8% | LYRA |
| FY2025 | $0M | $0M | -123601.7% | -7794.5% | LYRA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AVTX | LYRA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $448.7M | $2.3M | Larger Scale | AVTX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -69.3% | -87.2% | Higher Growth | AVTX |
| Operating Margin (TTM) Profitability | -161962.7% | -25032.0% | Higher Margin | LYRA |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -33.6% | -404.5% | Higher ROE | AVTX |
| 52-Week Range Position Momentum | 3% ($7โ$24) | 1% ($0โ$38) | Stronger Trend | AVTX |
| Beta / 30D Volatility Risk Regime | 1.74ฮฒ ยท 164% Vol | 0.33ฮฒ ยท 248% Vol | Lower Realized Risk | AVTX |
| Unified Institutional Score Composite Signal | 49.6 / 100 (HOLD) | 52.2 / 100 (HOLD) | Higher Composite | LYRA |